Excess Rates of Nonfatal Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel (Preventing Clinical Events or Chasing Enzymatic Ghosts?

Victor L. Serebruany

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1364-1366
Number of pages3
JournalThe American Journal of Cardiology
Volume101
Issue number9
DOIs
StatePublished - May 1 2008

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this